FDA Issues First Compounding Warning Letters Since New Law

Drug GMP Report
A A
The FDA has hit two compounding pharmacies with warning letters for quality violations and failure to have prescriptions for products they were compounding.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00